Putnam Investments’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $275M | Sell |
2,220,074
-259,028
| -10% | -$26.5M | 0.36% | 89 |
|
|
2023
Q3 | $231M | Buy |
2,479,102
+436,190
| +21% | +$49.2M | 0.35% | 86 |
|
|
2023
Q2 | $263M | Buy |
2,042,912
+226,508
| +12% | +$27.4M | 0.39% | 82 |
|
|
2023
Q1 | $211M | Sell |
1,816,404
-21,463
| -1% | -$2.4M | 0.34% | 89 |
|
|
2022
Q4 | $208M | Sell |
1,837,867
-142,295
| -7% | -$15.6M | 0.36% | 82 |
|
|
2022
Q3 | $159M | Sell |
1,980,162
-40,938
| -2% | -$3.47M | 0.3% | 89 |
|
|
2022
Q2 | $151M | Sell |
2,021,100
-48,492
| -2% | -$4.43M | 0.27% | 96 |
|
|
2022
Q1 | $265M | Buy |
2,069,592
+529,468
| +34% | +$57.9M | 0.4% | 78 |
|
|
2021
Q4 | $207M | Sell |
1,540,124
-185,872
| -11% | -$26.7M | 0.3% | 93 |
|
|
2021
Q3 | $236M | Sell |
1,725,996
-333,468
| -16% | -$42.1M | 0.37% | 84 |
|
|
2021
Q2 | $220M | Sell |
2,059,464
-44,840
| -2% | -$4.31M | 0.34% | 87 |
|
|
2021
Q1 | $189M | Buy |
2,104,304
+84,248
| +4% | +$7.91M | 0.32% | 90 |
|
|
2020
Q4 | $187M | Buy |
2,020,056
+255,324
| +14% | +$22.8M | 0.33% | 82 |
|
|
2020
Q3 | $182M | Buy |
1,764,732
+164,440
| +10% | +$17.2M | 0.36% | 79 |
|
|
2020
Q2 | $162M | Buy |
1,600,292
+485,832
| +44% | +$43.5M | 0.34% | 86 |
|
|
2020
Q1 | $75M | Buy |
+1,114,460
| New | +$69.3M | 0.2% | 119 |
|
|
2017
Q2 | – | Sell |
-59,792
| Closed | -$1.27M | – | 1157 |
|
|
2017
Q1 | $1.27M | Sell |
59,792
-8,872
| -13% | -$173K | ﹤0.01% | 958 |
|
|
2016
Q4 | $1.02M | Sell |
68,664
-1,132
| -2% | -$20.1K | ﹤0.01% | 1004 |
|
|
2016
Q3 | $1.53M | Sell |
69,796
-1,480,236
| -95% | -$32.9M | ﹤0.01% | 921 |
|
|
2016
Q2 | $30.7M | Buy |
1,550,032
+502,624
| +48% | +$8.56M | 0.07% | 228 |
|
|
2016
Q1 | $17.8M | Buy |
1,047,408
+822,792
| +366% | +$13.7M | 0.04% | 322 |
|
|
2015
Q4 | $4.6M | Buy |
224,616
+8,848
| +4% | +$184K | 0.01% | 687 |
|
|
2015
Q3 | $4.63M | Buy |
215,768
+43,780
| +25% | +$977K | 0.01% | 696 |
|
|
2015
Q2 | $3.44M | Buy |
171,988
+27,796
| +19% | +$488K | 0.01% | 870 |
|
|
2015
Q1 | $2.25M | Sell |
144,192
-6,724
| -4% | -$102K | ﹤0.01% | 1019 |
|
|
2014
Q4 | $2.08M | Sell |
150,916
-800
| -0.5% | -$9.79K | ﹤0.01% | 1015 |
|
|
2014
Q3 | $1.52M | Buy |
151,716
+2,876
| +2% | +$29.4K | ﹤0.01% | 1098 |
|
|
2014
Q2 | $1.48M | Buy |
148,840
+248
| +0.2% | +$2.2K | ﹤0.01% | 1107 |
|
|
2014
Q1 | $1.54M | Sell |
148,592
-10,660
| -7% | -$110K | ﹤0.01% | 1102 |
|
|
2013
Q4 | $1.41M | Sell |
159,252
-31,708
| -17% | -$251K | ﹤0.01% | 1133 |
|
|
2013
Q3 | $1.35M | Buy |
190,960
+64,500
| +51% | +$409K | ﹤0.01% | 1153 |
|
|
2013
Q2 | $710K | Buy |
+126,460
| New | +$606K | ﹤0.01% | 1263 |
|
Other funds holding DXCM
Putnam Investments's DXCM Position: Q4 2023 in Review
Putnam Investments reduced its DexCom (DXCM) stake by 10% in Q4 2023, selling an estimated $26.5M and leaving 2,220,074 shares worth $275M. The position accounts for 0.36% of the portfolio, ranked #89.
Putnam Investments first reported a position in DXCM in Q2 2013 and has held it in 32 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.
- Putnam Investments held 2,220,074 shares of DexCom worth $275M as of Q4 2023.
- Putnam Investments sold 259,028 DexCom shares in Q4 2023, an estimated $26.5M.
- DexCom made up 0.36% of Putnam Investments's portfolio in Q4 2023, its #89 holding.
- Putnam Investments first reported a position in DexCom in Q2 2013 and has held it in 32 quarters since.
- 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.